AthersysBiotechnology Company

ATIVESITE | Stroke Neurologist KOL Panel: TREASURE data for ischemic stroke



Five key opinion leaders (KOLs) in the field of stroke and a statistician to share their perspectives on the topline data from the TREASURE study conducted by the Athersys’ partner HEALIOS K.K. (Healios). The TREASURE study is a randomized, double-blind placebo-controlled study evaluating MultiStem (invimestrocel) administration, developed by Athersys, for the treatment of ischemic stroke. The trial enrolled 206 patients and was conducted at 48 sites in Japan.

Source Athersys YouTube

 

1111

ativesite

Health First, Well-Being Always!